Back to search

Article

The Impact of Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors: A Case Series on Metastatic Urothelial Carcinoma

2024-01-03

Abstract excerpt

<h4>Purpose: </h4> To investigate the disparities in tumor parenchyma and microenvironment between primary tumors and metastasis of urothelial carcinoma. Additionally, the study aims to determine whether the heterogeneity in these factors affects the predictive effectiveness of immune checkpoint inhibitors. <h4>Methods: </h4>: In this retrospective study, we investigated the treatment outcomes of 5 patients with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa9f2533-757f-5066-bb9c-b62b61c7e39e
DOI
10.21203/rs.3.rs-3825448/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Impact of Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors: A Case Series on Metastatic Urothelial CarcinomaDOI 10.21203/rs.3.rs-3825448/v1
Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary.Semantic proximity
Comparative genomic landscape of primary and metastatic bladder urothelial carcinoma in a large-scale cohort.Semantic proximity
Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment.Semantic proximity
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Semantic proximity
Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma.Semantic proximity
Clonal diversity shapes the tumour microenvironment leading to distinct immunotherapy responses in metastatic urothelial carcinomaSemantic proximity
Genomic case report of a low grade bladder tumor metastasis to lung.Semantic proximity
Mutations in TP53 and other heterogeneous genes help to distinguish metastases from new primary malignanciesSemantic proximity
Complete Response To Tislelizumab In A Muscle-Invasive Urothelial Carcinoma After Surgery Associated With Tumor Mutational Burden High: A Case ReportSemantic proximity
Histological variant-specific significance of lymph node metastasis for the prognosis of metastatic urothelial carcinoma treated with pembrolizumab: A retrospective multicentric study (YUSHIMA study-04)Semantic proximity
Bladder Adenocarcinoma in a Constellation of Multiple Site Malignancies: An Unusual Case and Systematic ReviewSemantic proximity
Four Metachronous Cancers: Mutation Profiling Can Be Used to Distinguish Multiple Primary Cancers from Metastases.Semantic proximity
Select a neighboring publication to make it the new centre.